Современные аспекты применения назальных сосудосуживающих и вспомогательных препаратов в педиатрической практике
2018
Nasal forms of vasoconstrictor agents (decongestants) are one of the most frequently prescribed groups of drugs in the therapy of inflammatory diseases of the nasal cavity. The article provides an overview of the mechanisms of action of decongestants, safety and the evidence base for the efficacy of decongestants in various upper respiratory tract diseases. It is concluded that when choosing a nasal agent, the preference should be given to decongestants with a higher level of safety – modern imidazolines (primarily xylometazoline) over the “first generation” decongestants (naphazoline).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI